|
Volumn 23, Issue 5, 2000, Pages 300-310
|
Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 ACETYL 7 OXO DEHYDROEPIANDROSTERONE;
7 OXO DEHYDROEPIANDROSTERONE 3BETA SULFATE;
ANDROSTANOLONE;
DRUG METABOLITE;
ESTRADIOL;
HYDROCORTISONE;
INSULIN;
PRASTERONE;
PRASTERONE SULFATE;
STEROID;
TESTOSTERONE;
THYROXINE;
UNCLASSIFIED DRUG;
ADULT;
ANEMIA;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD PRESSURE;
BODY WEIGHT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
GASTROINTESTINAL TOXICITY;
HEADACHE;
HEART RATE;
HORMONE ACTION;
HUMAN;
HYPERSENSITIVITY;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIMULATION;
ACETYLATION;
ADULT;
ANDROSTERONE;
DEHYDROEPIANDROSTERONE;
DIHYDROTESTOSTERONE;
DOUBLE-BLIND METHOD;
ESTRADIOL;
HUMANS;
HYDROCORTISONE;
INSULIN;
MALE;
MIDDLE AGED;
PLACEBOS;
TESTOSTERONE;
THYROXINE;
|
EID: 0033731577
PISSN: 0147958X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (25)
|